U.S. Pharmaceuticals & Biotech Insider-Bought Value Plays

Forum Markets

Market Cap: US$69.9m

A financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide.

Caris Life Sciences

Market Cap: US$4.4b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Phibro Animal Health

Market Cap: US$1.2b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Verrica Pharmaceuticals

Market Cap: US$100.8m

A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.

Fortress Biotech

Market Cap: US$88.0m

Operates as a biopharmaceutical company in the United States and internationally.

ImmuCell

Market Cap: US$88.6m

An animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.

Elite Pharmaceuticals

Market Cap: US$434.0m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Sofgen Pharma

Market Cap: US$58.1m

Develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe.

Champions Oncology

Market Cap: US$79.0m

A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Dyadic International

Market Cap: US$25.5m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.